Garodia Chemicals Ltd posted a profit of Rs 3.91 crore for FY26, a sharp reversal from the loss recorded in the previous year. Despite this financial shift, the company confirmed that manufacturing activities remain suspended due to intense market competition. Investors should note conflicting disclosures regarding insolvency proceedings found within the company's annual report, as well as a qualification from the statutory auditor regarding accounting software standards.
Garodia Chemicals Reports Rs 3.91 Crore Profit for FY26
Profit after tax for FY26 stood at Rs 3.91 crore, compared to a loss of Rs 20.76 lakh in the previous year.
Total income for the year was Rs 4.06 crore, derived primarily from other income sources.
Reader Takeaway: The company is profitable on paper via other income but lacks core operational revenue as manufacturing remains suspended.
What just happened
Garodia Chemicals released its annual report for the year ending March 31, 2026. While the bottom line shows a significant turnaround, this was largely driven by other income rather than operational sales. The company currently has no active manufacturing operations due to heavy market competition.
Why this matters
Shareholders face significant ambiguity regarding the company's status. The Directors' Report denies any insolvency filings under the IBC, yet the Secretarial Audit Report claims the NCLT Mumbai Bench has ordered the commencement of a pre-packaged insolvency resolution process. This discrepancy requires immediate clarification from the company's management.
Corporate Restructuring
Following a 2025 resolution plan and NCLT order, the company completed a capital reduction. It subsequently issued 5,000,000 equity shares to the incoming promoter, bringing total paid-up capital to Rs 52.63 lakh across 5,263,157 shares.
Auditor Observations
The statutory auditor, M/s. Laxmikant Kabra & Co., issued a qualified opinion noting that the company failed to use accounting software with an 'audit trail' facility. Management has committed to rectifying this compliance gap.
What to track next
The 34th Annual General Meeting is scheduled for September 30, 2026, via video conferencing. Investors should seek clarity on the contradictory insolvency disclosures and the timeline for a potential operational restart.